Search reports.
Chile Artificial Organs & Bionic Implants Market Trends 2031
Get free sample report Request for Customiztion Buy Now

Chile Artificial Organs & Bionic Implants Market Trends 2031

Segments - Chile Artificial Organs & Bionic Implants Market by Products (Artificial Organs [Artificial Heart, Artificial Kidney, and Others] and Bionics [Vision Bionics, Orthopedic Bionic, Cardiac Bionics and Others]), and Country - Chile Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3713 | 4.8 Rating | 76 Reviews | 165 Pages | Format : PDF Excel PPT

Report Description


The Chile Artificial Organs & Bionic Implants Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 11.49% during the forecast period, 2023 – 2031. The growth of the market is attributed to the rising demand for organ donors.

Artificial organs and Bionic implants are reconstructive surgery or devices that are specially made to embed in the human body to imitate the functioning of the original organ. The significant part of such implants is for them to work accurately such as normal organ without any disruption.

Chile Artificial Organs & Bionic Implants Market Outlook

Extreme shock, the deficit of blood, medication mistreat, and additional serious illnesses are some of the the main reasons behind the failure of the organ. Likewise, lifestyle complaints such as the necessity to smoke, liquor use, and harmful nutritional behavior are some causes of organ malfunction.

As per an article by Lycia Tramujas Vasconcellos Neumann distributed in 2018, the populace in Chile is aging at a high speed with an expected 64 million seniors living in the country by 2050.

The expanding demand for kidney, liver, heart, lungs, and, transplantation is adding to the development of the sector. To transplant a kidney, the standard mean waiting period is 5 years, in the US. While on holding up records, a ton of issues such as blood category, body dimensions, the seriousness of the complaint, and the remoteness from the donor can create challenges for the market.

Advancements in the field of 3D bio printing have been confirmed to be vital in organ transplanting, as it decreases the case of organ refusal.

  • Increasing cases of accidents and injuries are important factors is expected to contribute to the growth of the market during the forecast period.    

  • The development in medical care and the accessibility to sophisticated artificial support arrangements is estimated to support the demand for artificial organs and bionics.

  • Rising geriatric population is expected to spur the market growth.

  • Rapid adoption of technological advancements in the field of healthcare is fueling the growth of the market growth

  • Rising lifestyle disorders and consumption of drug or alcohol are key factors that can spur the market growth.

  • An improved regulatory environment and faster approval process is expected to foster the growth of the market.

  • Better services and improve existing procedures is expected to contribute to the growth of the market during the forecast period.

  • High cost of the procedure of artificial organs & bionic implants can hinder the growth of the market.

  • Government initiatives to control the chronicle diseases and policies in favor of the industry is estimated to drive the market growth.

Scope of the Report

The report on the Chile artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Artificial organs & bionic implants Market - Chile Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Artificial Organs [Artificial Heart, Artificial Kidney, and Others] and Bionics [Vision Bionics, Orthopedic Bionic, Cardiac Bionics and Others]

Country Scope

Chile

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Zimmer Biomet; Medtronic plc; Boston Scientific Corporation; Terumo Corporation and Otto Bock Holding GmbH & Co. KG.

 

Artificial Organs & Bionic Implants Market Segment Insights

Bionics segment is expected to grow at a rapid pace

Based on products, the market is divided into artificial organs and bionics. The artificial organs segment is further classified as artificial heart, artificial kidney, and others. The bionics segment is further segmented into vision bionics, orthopedics bionic, cardiac bionics and others. The cardiac bionics segment is estimated to account for a significant share of the market owing to the prevalence of cardiovascular diseases and increasing geriatric population in the country. Bionic cardiology is anticipated to advance the treatment for untreatable infections and can motivate more intricate applications in the coming years.

Chile Artificial Organs & Bionic Implants Market Products

Segments

The Chile artificial organs & bionic implants market has been segmented on the basis of

Products

  • Artificial Organs
    • Artificial Heart
    • Artificial Kidney
    • Others
  • Bionics
    • Vision Bionics
    • Orthopedic Bionic
    • Cardiac Bionics
    • Others

Country

  • Chile

Key Players

  • Zimmer Biomet
  • Medtronic plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • Otto Bock Holding GmbH & Co. KG

Competitive Landscape

Key players competing in the Chile artificial organs & bionic implants market are Zimmer Biomet; Medtronic plc; Boston Scientific Corporation; Terumo Corporation and Otto Bock Holding GmbH & Co. KG.

In February 2020, Ekso Bionics Holdings, Inc. worked together with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care hospitals.

In February 2018, A joint advancement understanding for a stomach aortic aneurysm stent graft has been finished up between Jikei University School of Medicine and Asahi Kasei Corp.

In January 2018, Boston Scientific got a FDA endorsement for Spectra WaveWriterT Spinal Cord Stimulator System.

Chile Artificial Organs & Bionic Implants Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionic Implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs & Bionic Implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs & Bionic Implants Market - Supply Chain
  4.5. Global Artificial Organs & Bionic Implants Market Forecast
     4.5.1. Artificial Organs & Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs & Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs & Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
6. North America Artificial Organs & Bionic Implants Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
7. Latin America Artificial Organs & Bionic Implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
8. Europe Artificial Organs & Bionic Implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
9. Asia Pacific Artificial Organs & Bionic Implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
10. Middle East & Africa Artificial Organs & Bionic Implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Artificial Organs & Bionic Implants Market: Market Share Analysis
  11.2. Artificial Organs & Bionic Implants Distributors and Customers
  11.3. Artificial Organs & Bionic Implants Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Zimmer Biomet
     11.4.2. Medtronic plc
     11.4.3. Boston Scientific Corporation
     11.4.4. Terumo Corporation
     11.4.5. Otto Bock Holding GmbH & Co. KG

Methodology

Our Clients

sinopec
Honda Motor Co. Ltd.
General Electric
Siemens Healthcare
Nestle SA
General Mills
Pfizer
Dassault Aviation